Precipio: Rises on launch of blood cancer test

Precipio

10/05/2021 16:44

** Diagnostics co's shares  PRPO.O  rise 21.6% to $4.6
    ** Co launches new testing panel for Acute Myeloid Leukemia
(AML) diagnosis (https://refini.tv/2Q4CLc7)
    ** AML is a type of cancer that affects blood and bone
marrow
    ** Panel uses blood samples to test patient for AML and
provides results in about 4 hours - PRPO
    ** Stock has more than doubled YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))